The firm is a subsidiary of Korean beauty company CLIO, home to several popular cosmetics brands, including Clio, PeriPera, Goodal, and Dermatory. It was established to expand into the health and wellness sector, particularly the beauty-from-within category.
Following the Japan debut of its ingestible beauty brand TRUE RX in 2024, Clio Life Care hired a new CEO, Kim Ji-yeon, in January 2025 to accelerate its growth.
Kim has 24 years of experience in the health functional foods industry. Since her arrival, the company has implemented a series of organizational restructuring initiatives, including product portfolio enhancement and distribution strategy streamlining.
According to the company, its strategy, driven by expansion of product lines and distribution channels, is yielding tangible results. As of the third quarter of 2025, quarterly sales reached KRW2.5bn (USD1.7m), representing an approximately 80% year-on-year growth.
Beyond its existing inner beauty products, such as collagen and glutathione, TRUE RX has ventured further into the wider wellness category, with its line-up now consisting of other dietary supplements and health functional foods, including vaginal health probiotic and blood sugar management supplements, enzyme sticks, and borage oil capsules.
The brand has also implemented a distribution diversification strategy, leveraging new channels like home shopping and crowdfunding.
It said that its new products have especially performed well. For instance, TRUE RX Wego Sac, which is formulated with the patented and well-documented L.casei 431 probiotic strain, achieved an initial demand rate of approximately 3,500% in a pre-launch crowdfunding campaign, and is currently in the second round of funding.
The campaign is being held on Wadiz, South Korea’s largest and leading crowdfunding platform.
Another example is TRUE RX Ace Organic Olive Oil, which was launched through a home shopping platform in Korea last July and sold out all quantities by the eighth broadcast.
The product comes in a sachet format, with each individually packed sachet containing olive oil made solely from organic Greek Koroneiki olives. It has been certified as an organic processed food by Japan’s Ministry of Agriculture, Forestry and Fisheries.
Based on its vision of “providing real health solutions tailored to the life cycle and for ultra-fast absorption”, the brand intends to focus on providing personalized products for consumers.
Poised for big role
Building on this growth momentum, Clio Life Care plans to step up its business expansion strategy in 2026.
Key strategies include broadening its portfolio of functional foods, specific planning for each sales channel, and securing a global distribution network.
In the long term, the firm plans to cement its health functional foods line as an independent growth pillar.
“We are securing a second growth engine for the company by expanding the customer base and marketing capabilities built through the cosmetics business into the health functional foods sector.
“This year, we will establish a stable growth trajectory by strengthening our brand awareness and expanding our product line-up,” Kim said.
In addition, Clio Life Care looks to pursue sustainable growth based on transparent and ethical management, and actively implement the company’s ESG management to fulfil corporate social responsibility.
